Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer

A new approach for using extracellular vesicles (EVs) to deliver tyrosine kinase inhibitors (TKIs) to enhance iodine avidity in radioactive iodine-refractory thyroid cancer is needed. We isolated and characterized primary human adipose-derived stem cells (ADSCs) and isolated their EVs. The EVs were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Rajendran, Ramya Lakshmi, Paudel, Sanjita, Gangadaran, Prakash, Oh, Ji Min, Oh, Eun Jung, Hong, Chae Moon, Lee, Sangkyu, Chung, Ho Yun, Lee, Jaetae, Ahn, Byeong-Cheol
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7916551/
https://ncbi.nlm.nih.gov/pubmed/33578882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020248
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados